Response rate as an endpoint in clinical trials

被引：22

作者：

George, Stephen L. ^{[1
]}

机构：

[1] Duke Univ, Med Ctr, Canc Ctr Biostat, Durham, NC 27705 USA

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2007年 / 99卷 / 02期

关键词：

D O I：

10.1093/jnci/djk024

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：98 / 99

页数：2

共 9 条

[1] Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients [J].

Bruzzi, P ;

Del Mastro, L ;

Sormani, MP ;

Bastholt, L ;

Danova, M ;

Focan, C ;

Fountzilas, G ;

Paul, J ;

Rosso, R ;

Venturini, M .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5117-5125

[2]

Buyse M, 1996, STAT MED, V15, P2797, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2797::AID-SIM290>3.0.CO

[3]

2-V

[4] Considerations in the evaluation of surrogate endpoints in clinical trials: Summary of a National Institutes of Health Workshop [J].

De Gruttola, VG ;

Clax, P ;

DeMets, DL ;

Downing, GJ ;

Ellenberg, SS ;

Friedman, L ;

Gail, MH ;

Prentice, R ;

Wittes, J ;

Zeger, SL .

CONTROLLED CLINICAL TRIALS, 2001, 22 (05) :485-502

[5] Objective response rate as a surrogate end point: A commentary [J].

Fleming, TR .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :4845-4846

[6] Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup [J].

Lewis, Ian J. ;

Nooij, Marianne A. ;

Whelan, Jeremy ;

Sydes, Matthew R. ;

Grimer, Robert ;

Hogendoorn, Pancras C. W. ;

Memon, Muhammad A. ;

Weeden, Simon ;

Uscinska, Barbara M. ;

van Glabbeke, Martine ;

Kirkpatrick, Anne ;

Hauben, Esther I. ;

Craft, Alan W. ;

Taminiau, Antonie H. M. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (02) :112-128

[7] A perspective on surrogate endpoints in controlled clinical trials [J].

Molenberghs, G ;

Burzykowski, T ;

Alonso, A ;

Buyse, M .

STATISTICAL METHODS IN MEDICAL RESEARCH, 2004, 13 (03) :177-206

[8] Response rates, survival, and chemotherapy trials [J].

Pazdur, R .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (19) :1552-1553

[9] STATISTICAL-MODEL TO DETERMINE THE RELATIONSHIP OF RESPONSE AND SURVIVAL IN PATIENTS WITH ADVANCED OVARIAN-CANCER TREATED WITH CHEMOTHERAPY [J].

TORRI, V ;

SIMON, R ;

RUSSEKCOHEN, E ;

MIDTHUNE, D ;

FRIEDMAN, M .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (06) :407-414

← 1 →